Treatment of hypertension in patients undergoing coronary artery by-pass grafting
Highlights ► Hypertension worsens prognosis and increases risk of complications in CABG patients. ► Anti-hypertensive drugs should be continued prior surgery only in stable patients. ► Excessive blood pressure variations during CABG should be avoided. ► Beta-blocker therapy should be started immedia...
Gespeichert in:
| Veröffentlicht in: | Current opinion in pharmacology 2012-04, Vol.12 (2), p.127-133 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 133 |
|---|---|
| container_issue | 2 |
| container_start_page | 127 |
| container_title | Current opinion in pharmacology |
| container_volume | 12 |
| creator | Krzych, Lukasz J |
| description | Highlights ► Hypertension worsens prognosis and increases risk of complications in CABG patients. ► Anti-hypertensive drugs should be continued prior surgery only in stable patients. ► Excessive blood pressure variations during CABG should be avoided. ► Beta-blocker therapy should be started immediately after CABG. ► Early administration of ACE inhibitors does not appear to improve clinical outcome. |
| doi_str_mv | 10.1016/j.coph.2012.01.008 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1018635015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1471489212000094</els_id><sourcerecordid>1018635015</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-226d43a86344bae8815aa52e123390a39b712837e159b2153d066789091a9e823</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxUVpaJJtv0APxcde7Ggk_xOEQglpEwiEkPQsZHl2o61XciQ7sN8-YzbpoYfoMgK999D7DWNfgRfAoT7bFjaMj4XgIAoOBeftB3YCZQN5qRr58e3eKnHMTlPacg6VlM0ndiyELAXU1Qm7e4hoph36KQvr7HE_YpzQJxd85nw2msnRU8pm32PcBOc3mQ0xeBP3mSEljW6fjyalbBPNeiLBZ3a0NkPCL69zxf78uny4uMpvbn9fX_y8yW0JMOVC1H0pTVvLsuwMti1UxlQCQUipuJGqa0C0skGoVCfo4z2v66ZVXIFR2Aq5Yt8PuWMMTzOmSe9csjgMxmOYkyZEFF4tnVdMHKQ2hpQirvUY3Y46kGjR1XqrF5R6Qak5aEJJpm-v-XO3w_6f5Y0dCc4PAqSWzw6jTpZoWexdRDvpPrj383_8Z7eD886a4S_uMW3DHD3x06ATefT9ssxllyA4HVXKF0m0mNc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1018635015</pqid></control><display><type>article</type><title>Treatment of hypertension in patients undergoing coronary artery by-pass grafting</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Krzych, Lukasz J</creator><creatorcontrib>Krzych, Lukasz J</creatorcontrib><description>Highlights ► Hypertension worsens prognosis and increases risk of complications in CABG patients. ► Anti-hypertensive drugs should be continued prior surgery only in stable patients. ► Excessive blood pressure variations during CABG should be avoided. ► Beta-blocker therapy should be started immediately after CABG. ► Early administration of ACE inhibitors does not appear to improve clinical outcome.</description><identifier>ISSN: 1471-4892</identifier><identifier>EISSN: 1471-4973</identifier><identifier>DOI: 10.1016/j.coph.2012.01.008</identifier><identifier>PMID: 22342165</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adrenergic beta-Antagonists - therapeutic use ; Antihypertensive Agents - therapeutic use ; Coronary Artery Bypass ; Humans ; Hypertension - drug therapy ; Internal Medicine ; Medical Education</subject><ispartof>Current opinion in pharmacology, 2012-04, Vol.12 (2), p.127-133</ispartof><rights>Elsevier Ltd</rights><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-226d43a86344bae8815aa52e123390a39b712837e159b2153d066789091a9e823</citedby><cites>FETCH-LOGICAL-c411t-226d43a86344bae8815aa52e123390a39b712837e159b2153d066789091a9e823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.coph.2012.01.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22342165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krzych, Lukasz J</creatorcontrib><title>Treatment of hypertension in patients undergoing coronary artery by-pass grafting</title><title>Current opinion in pharmacology</title><addtitle>Curr Opin Pharmacol</addtitle><description>Highlights ► Hypertension worsens prognosis and increases risk of complications in CABG patients. ► Anti-hypertensive drugs should be continued prior surgery only in stable patients. ► Excessive blood pressure variations during CABG should be avoided. ► Beta-blocker therapy should be started immediately after CABG. ► Early administration of ACE inhibitors does not appear to improve clinical outcome.</description><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Coronary Artery Bypass</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Internal Medicine</subject><subject>Medical Education</subject><issn>1471-4892</issn><issn>1471-4973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9r3DAQxUVpaJJtv0APxcde7Ggk_xOEQglpEwiEkPQsZHl2o61XciQ7sN8-YzbpoYfoMgK999D7DWNfgRfAoT7bFjaMj4XgIAoOBeftB3YCZQN5qRr58e3eKnHMTlPacg6VlM0ndiyELAXU1Qm7e4hoph36KQvr7HE_YpzQJxd85nw2msnRU8pm32PcBOc3mQ0xeBP3mSEljW6fjyalbBPNeiLBZ3a0NkPCL69zxf78uny4uMpvbn9fX_y8yW0JMOVC1H0pTVvLsuwMti1UxlQCQUipuJGqa0C0skGoVCfo4z2v66ZVXIFR2Aq5Yt8PuWMMTzOmSe9csjgMxmOYkyZEFF4tnVdMHKQ2hpQirvUY3Y46kGjR1XqrF5R6Qak5aEJJpm-v-XO3w_6f5Y0dCc4PAqSWzw6jTpZoWexdRDvpPrj383_8Z7eD886a4S_uMW3DHD3x06ATefT9ssxllyA4HVXKF0m0mNc</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Krzych, Lukasz J</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120401</creationdate><title>Treatment of hypertension in patients undergoing coronary artery by-pass grafting</title><author>Krzych, Lukasz J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-226d43a86344bae8815aa52e123390a39b712837e159b2153d066789091a9e823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Coronary Artery Bypass</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Internal Medicine</topic><topic>Medical Education</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krzych, Lukasz J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krzych, Lukasz J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of hypertension in patients undergoing coronary artery by-pass grafting</atitle><jtitle>Current opinion in pharmacology</jtitle><addtitle>Curr Opin Pharmacol</addtitle><date>2012-04-01</date><risdate>2012</risdate><volume>12</volume><issue>2</issue><spage>127</spage><epage>133</epage><pages>127-133</pages><issn>1471-4892</issn><eissn>1471-4973</eissn><abstract>Highlights ► Hypertension worsens prognosis and increases risk of complications in CABG patients. ► Anti-hypertensive drugs should be continued prior surgery only in stable patients. ► Excessive blood pressure variations during CABG should be avoided. ► Beta-blocker therapy should be started immediately after CABG. ► Early administration of ACE inhibitors does not appear to improve clinical outcome.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>22342165</pmid><doi>10.1016/j.coph.2012.01.008</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1471-4892 |
| ispartof | Current opinion in pharmacology, 2012-04, Vol.12 (2), p.127-133 |
| issn | 1471-4892 1471-4973 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1018635015 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Adrenergic beta-Antagonists - therapeutic use Antihypertensive Agents - therapeutic use Coronary Artery Bypass Humans Hypertension - drug therapy Internal Medicine Medical Education |
| title | Treatment of hypertension in patients undergoing coronary artery by-pass grafting |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A01%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20hypertension%20in%20patients%20undergoing%20coronary%20artery%20by-pass%20grafting&rft.jtitle=Current%20opinion%20in%20pharmacology&rft.au=Krzych,%20Lukasz%20J&rft.date=2012-04-01&rft.volume=12&rft.issue=2&rft.spage=127&rft.epage=133&rft.pages=127-133&rft.issn=1471-4892&rft.eissn=1471-4973&rft_id=info:doi/10.1016/j.coph.2012.01.008&rft_dat=%3Cproquest_cross%3E1018635015%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1018635015&rft_id=info:pmid/22342165&rft_els_id=S1471489212000094&rfr_iscdi=true |